1. Home
  2. TSHA vs SKYT Comparison

TSHA vs SKYT Comparison

Compare TSHA & SKYT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TSHA
  • SKYT
  • Stock Information
  • Founded
  • TSHA 2019
  • SKYT 1991
  • Country
  • TSHA United States
  • SKYT United States
  • Employees
  • TSHA N/A
  • SKYT N/A
  • Industry
  • TSHA Biotechnology: Pharmaceutical Preparations
  • SKYT Semiconductors
  • Sector
  • TSHA Health Care
  • SKYT Technology
  • Exchange
  • TSHA Nasdaq
  • SKYT Nasdaq
  • Market Cap
  • TSHA 403.7M
  • SKYT 426.4M
  • IPO Year
  • TSHA 2020
  • SKYT 2021
  • Fundamental
  • Price
  • TSHA $2.00
  • SKYT $17.22
  • Analyst Decision
  • TSHA Strong Buy
  • SKYT Strong Buy
  • Analyst Count
  • TSHA 8
  • SKYT 4
  • Target Price
  • TSHA $6.63
  • SKYT $12.75
  • AVG Volume (30 Days)
  • TSHA 5.4M
  • SKYT 646.9K
  • Earning Date
  • TSHA 11-13-2024
  • SKYT 11-07-2024
  • Dividend Yield
  • TSHA N/A
  • SKYT N/A
  • EPS Growth
  • TSHA N/A
  • SKYT N/A
  • EPS
  • TSHA N/A
  • SKYT N/A
  • Revenue
  • TSHA $9,915,000.00
  • SKYT $345,935,000.00
  • Revenue This Year
  • TSHA N/A
  • SKYT $21.36
  • Revenue Next Year
  • TSHA N/A
  • SKYT N/A
  • P/E Ratio
  • TSHA N/A
  • SKYT N/A
  • Revenue Growth
  • TSHA N/A
  • SKYT 26.89
  • 52 Week Low
  • TSHA $1.19
  • SKYT $5.63
  • 52 Week High
  • TSHA $4.32
  • SKYT $13.55
  • Technical
  • Relative Strength Index (RSI)
  • TSHA 41.45
  • SKYT 88.97
  • Support Level
  • TSHA $1.97
  • SKYT $8.90
  • Resistance Level
  • TSHA $2.72
  • SKYT $9.61
  • Average True Range (ATR)
  • TSHA 0.23
  • SKYT 1.06
  • MACD
  • TSHA -0.10
  • SKYT 0.78
  • Stochastic Oscillator
  • TSHA 2.24
  • SKYT 98.10

About TSHA Taysha Gene Therapies Inc.

Taysha Gene Therapies Inc is a patient-centric gene therapy company to eradicate monogenic CNS disease. It is focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the CNS in both rare and large patient populations. The company develops and commercializes transformative gene therapy treatments. Its product pipeline includes TSHA-102 which is a is a self-complementary intrathecally delivered AAV9 gene transfer therapy in clinical evaluation for Rett syndrome.

About SKYT SkyWater Technology Inc.

SkyWater Technology Inc is a U.S.-based, independent, pure-play technology foundry that offers semiconductor development and manufacturing services from its fabrication facilities. In its technology as a service model, it leverages a foundation of proprietary technology, engineering to co-develop process technology intellectual property (IP) with its customers that enable disruptive concepts through its Technology Services for diverse microelectronics (integrated circuits) and related micro- and nanotechnology applications. It focuses on serving diversified, high-growth, end users in numerous vertical markets, including computation, aerospace and defense (A&D), automotive and transportation, bio-health, and industrial.

Share on Social Networks: